273 related articles for article (PubMed ID: 34557068)
1. Characterizing the Retinal Phenotype of the Thy1-h[A30P]α-syn Mouse Model of Parkinson's Disease.
Veys L; Devroye J; Lefevere E; Cools L; Vandenabeele M; De Groef L
Front Neurosci; 2021; 15():726476. PubMed ID: 34557068
[TBL] [Abstract][Full Text] [Related]
2. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
3. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.
Price DL; Rockenstein E; Mante M; Adame A; Overk C; Spencer B; Duong-Polk KX; Bonhaus D; Lindsey J; Masliah E
Sci Rep; 2016 Jul; 6():29523. PubMed ID: 27389831
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-10a inhibits A30P α-synuclein aggregation and toxicity by targeting proapoptotic protein BCL2L11.
Liang H; Ding B; Liang J; Shi X; Jiang X; Gao Y
Int J Clin Exp Pathol; 2018; 11(2):624-633. PubMed ID: 31938148
[TBL] [Abstract][Full Text] [Related]
6. Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.
Mammadova N; Baron T; Verchère J; Greenlee JJ; Greenlee MHW
Methods Mol Biol; 2021; 2224():75-85. PubMed ID: 33606207
[TBL] [Abstract][Full Text] [Related]
7. Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.
Baksi S; Tripathi AK; Singh N
Free Radic Biol Med; 2016 Aug; 97():292-306. PubMed ID: 27343690
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the Retina of Plp-α-Syn Mice as a Model for Studying Synuclein-Dependent Diseases.
Kaehler K; Seitter H; Sandbichler AM; Tschugg B; Obermair GJ; Stefanova N; Koschak A
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):12. PubMed ID: 32503050
[TBL] [Abstract][Full Text] [Related]
9. Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages.
Nuber S; Petrasch-Parwez E; Arias-Carrión O; Koch L; Kohl Z; Schneider J; Calaminus C; Dermietzel R; Samarina A; Boy J; Nguyen HP; Teismann P; Velavan TP; Kahle PJ; von Hörsten S; Fendt M; Krüger R; Riess O
Neurobiol Dis; 2011 Nov; 44(2):192-204. PubMed ID: 21767644
[TBL] [Abstract][Full Text] [Related]
10. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
[TBL] [Abstract][Full Text] [Related]
11. Retinal alpha-synuclein accumulation correlates with retinal dysfunction and structural thinning in the A53T mouse model of Parkinson's disease.
Tran KKN; Wong VHY; Hoang A; Finkelstein DI; Bui BV; Nguyen CTO
Front Neurosci; 2023; 17():1146979. PubMed ID: 37214398
[TBL] [Abstract][Full Text] [Related]
12. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
13. Expression of α-Synuclein in the mouse retina is confined to inhibitory presynaptic elements.
Yang Q; Lin X; Xiao J; Zhong W; Wang F; Tan H; Rao B; Qu J; Zhang J
J Comp Neurol; 2023 Jul; 531(10):1057-1079. PubMed ID: 37002599
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease.
Bellucci A; Bubacco L; Longhena F; Parrella E; Faustini G; Porrini V; Bono F; Missale C; Pizzi M
Front Aging Neurosci; 2020; 12():68. PubMed ID: 32265684
[TBL] [Abstract][Full Text] [Related]
15. Levodopa Rescues Retinal Function in the Transgenic A53T Alpha-Synuclein Model of Parkinson's Disease.
Tran KKN; Wong VHY; Vessey KA; Finkelstein DI; Bui BV; Nguyen CTO
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255235
[TBL] [Abstract][Full Text] [Related]
16. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
17. Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model.
Kahle PJ; Neumann M; Ozmen L; Müller V; Odoy S; Okamoto N; Jacobsen H; Iwatsubo T; Trojanowski JQ; Takahashi H; Wakabayashi K; Bogdanovic N; Riederer P; Kretzschmar HA; Haass C
Am J Pathol; 2001 Dec; 159(6):2215-25. PubMed ID: 11733371
[TBL] [Abstract][Full Text] [Related]
18. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
Lee MK; Stirling W; Xu Y; Xu X; Qui D; Mandir AS; Dawson TM; Copeland NG; Jenkins NA; Price DL
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8968-73. PubMed ID: 12084935
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease.
Bridi JC; Hirth F
Front Neurosci; 2018; 12():80. PubMed ID: 29515354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
